We are live on ! Find out more
CCM

Crossvault Capital Management Portfolio holdings

AUM $254M
1-Year Est. Return 5.07%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
-5.07%
3 Year Est. Return
+56.38%
5 Year Est. Return
+114.39%
10 Year Est. Return
AUM
$114M
AUM Growth
+$8.31M
Cap. Flow
+$3.95M
Cap. Flow %
3.45%
Top 10 Hldgs %
39.09%
Holding
65
New
5
Increased
21
Reduced
21
Closed
4

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$2.04M
2
SLB icon
SLB Ltd
SLB
+$1.5M
3
GILD icon
Gilead Sciences
GILD
+$1.44M
4
PEP icon
PepsiCo
PEP
+$777K
5
COP icon
ConocoPhillips
COP
+$650K

Sector Composition

Rank Sector Weight
1 Healthcare 21.95%
2 Energy 14.07%
3 Consumer Discretionary 11.04%
4 Industrials 10.78%
5 Technology 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$6.29M 5.51%
106,648
-705
-0.7% -$39.8K
AAPL icon
2
Apple
AAPL
$4.9T
$5.7M 4.99%
206,532
+1,580
+0.8% +$43K
SBUX icon
3
Starbucks
SBUX
$120B
$4.58M 4.01%
111,700
-50
-0% -$1.95K
NKE icon
4
Nike
NKE
$64.9B
$4.47M 3.91%
92,904
-700
-0.7% -$32.8K
COP icon
5
ConocoPhillips
COP
$140B
$4.07M 3.56%
58,936
+9,315
+19% +$650K
PFE icon
6
Pfizer
PFE
$143B
$3.98M 3.48%
134,502
+6,205
+5% +$178K
ABBV icon
7
AbbVie
ABBV
$450B
$3.96M 3.47%
60,572
+150
+0.2% +$9.46K
TGNA
8
DELISTED
TEGNA Inc
TGNA
$3.93M 3.44%
235,455
-9,367
-4% -$151K
JNJ icon
9
Johnson & Johnson
JNJ
$609B
$3.91M 3.42%
37,377
+125
+0.3% +$13.2K
GE icon
10
GE Aerospace
GE
$364B
$3.76M 3.29%
31,077
-1,674
-5% -$206K
PNC icon
11
PNC Financial Services
PNC
$101B
$3.74M 3.27%
40,955
-950
-2% -$82.3K
DD icon
12
DuPont de Nemours
DD
$18.3B
$3.59M 3.14%
31,093
+2,280
+8% +$278K
CLX icon
13
Clorox
CLX
$11.6B
$3.46M 3.03%
33,185
-200
-0.6% -$20K
WFM
14
DELISTED
Whole Foods Market Inc
WFM
$3.22M 2.82%
63,830
+235
+0.4% +$10.4K
MS icon
15
Morgan Stanley
MS
$339B
$3.17M 2.77%
81,700
+3,025
+4% +$108K
ROK icon
16
Rockwell Automation
ROK
$51.4B
$3.08M 2.7%
27,735
+600
+2% +$65.8K
UNH icon
17
UnitedHealth
UNH
$387B
$3.06M 2.68%
30,255
-15,065
-33% -$1.43M
SLB icon
18
SLB Ltd
SLB
$70.3B
$3.05M 2.67%
35,715
+16,275
+84% +$1.5M
HON icon
19
Honeywell
HON
$71.3B
$2.91M 2.55%
32,385
+23,682
+272% +$2.04M
KRFT
20
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$2.62M 2.29%
41,734
+850
+2% +$49.7K
DINO icon
21
HF Sinclair
DINO
$16B
$2.5M 2.19%
66,610
-19,200
-22% -$800K
T icon
22
AT&T
T
$152B
$2.29M 2.01%
90,434
+6,917
+8% +$179K
OXY icon
23
Occidental Petroleum
OXY
$54.6B
$2.27M 1.99%
28,223
-1,655
-6% -$137K
XOM icon
24
ExxonMobil
XOM
$611B
$2.19M 1.92%
23,745
+2,089
+10% +$195K
AMZN icon
25
Amazon
AMZN
$2.66T
$1.89M 1.65%
121,800
+6,800
+6% +$106K

Similar funds

Crossvault Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Crossvault Capital Management held 65 positions worth $114M, up 7.8% from $106M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Crossvault Capital Management deployed $3.95M of net new capital in Q4 2014, opening 5 new positions and adding to 21 existing holdings. Its largest new stake was Gilead Sciences: 13,875 shares worth $1.31M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.43M trimmed.

  • Crossvault Capital Management's largest Q4 2014 buy was Gilead Sciences: 13,875 shares worth $1.31M.
  • Crossvault Capital Management added most to Honeywell in Q4 2014, an estimated $2.04M increase.
  • Crossvault Capital Management's biggest Q4 2014 reduction was UnitedHealth, cutting an estimated $1.43M.
  • Crossvault Capital Management fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $248K.
  • Crossvault Capital Management's ten largest holdings make up 39% of its $114M portfolio in Q4 2014.
  • Crossvault Capital Management opened 5 new positions and closed 4 in Q4 2014.
  • Crossvault Capital Management's portfolio value rose 7.8% quarter-over-quarter to $114M.

Based on Crossvault Capital Management's 13F filing for Q4 2014, filed 22 Jan 2015.